UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003297
Receipt number R000003991
Scientific Title Pilot study of plasma acylcarnitinine profiles after meal load in Japanese patients with type 2 diabetes patients
Date of disclosure of the study information 2010/04/01
Last modified on 2010/03/07 22:40:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pilot study of plasma acylcarnitinine profiles after meal load in Japanese patients with type 2 diabetes patients

Acronym

Pilot study of plasma acylcarnitinine profiles after meal load in Japanese patients with type 2 diabetes patients

Scientific Title

Pilot study of plasma acylcarnitinine profiles after meal load in Japanese patients with type 2 diabetes patients

Scientific Title:Acronym

Pilot study of plasma acylcarnitinine profiles after meal load in Japanese patients with type 2 diabetes patients

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Final aim is to find a novel plasma marker related to fatty acid metabolism to predict insulin resistance in subjects with glucose intolerance. As pilot study, plasma acylcarnitinine profiles after meal load are measured in non-diabetcic and diabetic subjects to obtain fundamental information for future full study.

Basic objectives2

Others

Basic objectives -Others

Plasma acylcarnitinine profiles after meal load are measured and are compared in non-diabetcic and diabetic subjects

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Difference of plasma acylcarnitinine profiles after meal load in non-diabetcic and diabetic subjects

Key secondary outcomes

Relation of plasma acylcarnitinine profiles after meal load to HOMA-R


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with type 2 diabetes who are not treated with insulin.

Healthy volunteers in whom previous blood and urinary glucose tests were normal.

Key exclusion criteria

Subjects using steroid/Subjects using beta blocker or beta stimulant/Subjects taking protein and fat restriction/Subjects with fever or inflammation/Subjects with malignancy/Pregnant subjects/Subjects who consume large amounts of alcohol/Subjects who cannot bear resting position/Subjects with dementia/Subjects with disability in daily activity

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shimpei Fujimoto

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Diabetes and Clinical Nutrition

Zip code


Address

54 Shogoin Kawahara-cho, Sakyo-tu, Kyoto 606-8507

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Diabetes and Clinical Nutrition

Zip code


Address


TEL


Homepage URL


Email

fujimoto@metab.kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Diabetes and Clinical Nutrition, Graduate School of Medicine, Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Project for Biosimulation from the Ministry of Education, Culture, Sports, Science and Technology of Japan

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学医学部附属病院(京都府)


Other administrative information

Date of disclosure of the study information

2010 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2010 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Plasma acylcarnitinine profiles after meal load are compared in non-diabetcic and diabetic subjects. Relation of plasma acylcarnitinine to HOMA-R is analyzed.


Management information

Registered date

2010 Year 03 Month 07 Day

Last modified on

2010 Year 03 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003991


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name